The emerging anti-inflammatory role of HDL-cholesterol, illustrated in cardiovascular disease free population; the ATTICA study

International Journal of Cardiology

Volumn 122, Issue 1, 2007, Pages 29-33

  Chrysohoou, Christina ^a   Pitsavos, Christos ^a   Skoumas, John ^a   Masoura, Constantina ^a   Katinioti, Anastasia ^a   Panagiotakos, Demosthenes ^b   Stefanadis, Christodoulos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b HAROKOPIO UNIVERSITY   (Greece)

Author keywords

Atherosclerosis; HDL cholesterol; Inflammation

Indexed keywords

AMYLOID A PROTEIN; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 6;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; DISEASE MARKER; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; GREECE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ADULT; C-REACTIVE PROTEIN; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; DIET; FEMALE; GREECE; HEALTH STATUS; HOMOCYSTEINE; HUMANS; INTERLEUKIN-6; LIFE STYLE; MALE; MIDDLE AGED; REGRESSION ANALYSIS; SERUM AMYLOID A PROTEIN; SEX FACTORS;

EID: 34848823776     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.010     Document Type: Article

References (32)

1. Gotto Jr. A.M. Lipid and lipoprotein disorders. In: Pearson T.A., Criqui M.H., Luepker R.V., Oberman A., and Wilson M. (Eds). Primer in Preventive Cardiology (1994), American Heart Association, Dallas, Tex 107-129
2. Ginsberg H.N. Lipoprotein metabolism and its relationship to atherosclerosis. Med Clin North Am 78 (1994) 1-20
3. Wilson P.W.F., Abbott R.D., and Castelli W.P. High density lipoprotein cholesterol and mortality. Arteriosclerosis 8 (1988) 737-741
4. Executive summary of the third report of the National Cholesterol Educational Program Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285 19 (2001) 2486-2497
5. Navab M., Berliner J.A., Subbanagounder G., et al. HDL and the inflammatory response induced by LDL-derived oxidized phospholipids. Atheroscler Thromb Vasc Biol 21 (2001) 481-488
6. Trichopoulou A., Costacou T., Bamia C., and Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 348 (2003) 2599-2608
7. Trichopoulou A. From research to education: the Greek experience. Nutrition 16 (2000) 528-531
8. Willett W.C., Sacks F., Trichopoulou A., et al. Mediterranean diet pyramid: a cultural model for healthy eating. Am J Clin Nutr 6 (1995) 1402S-1406S
9. Panagiotakos D., Pistavos C., and Stefanadis C. Dietary patterns: A Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk. Nutr Metab Cardiovasc Dis 16 (2006) 559-568
10. Panagiotakos D.B., Pitsavos H., Chrysohoou C., et al. Status and Management of Hypertension, in Greece; the role of the adoption of Mediterranean Diet: the ATTICA study. J Hypertens 21 (2003) 1483-1489
11. Nofer J.R., Kehrel B., Fobker M., Levkau B., Assmann G., and von Eckardstein A. HDL and atherosclerosis: beyond reverse cholesterol transport. Atherosclerosis 161 (2002) 1-16
12. Fogelman A.M. When does good cholesterol goes bad. Nat Med 10 (2004) 902-903
13. Panagiotakos D.B., Pitsavos C., Skoumas J., et al. The importance of LDL/HDL-cholesterol ratio as a predictor for coronary heart disease events, in patients with heterozygous familial hypercholesterolemia: a 15-year follow-up (1987-2002). Curr Med Res Opin 19 2 (2003) 89-94
14. Wadham C., Albanese N., Roberts J., et al. High-density lipoproteins neutralize C-reactive protein proinflammatory activity. Circulation 109 (2004) 2116-2122
15. Baker P.W., Rye K.A., Gamble J.R., Vadas M.A., and Barter P.J. Ability of reconstituted high density lipoproteins to inhibit cytokine-induced expression of vascular cell adhesion molecule-1 in human umbilical vein endothelial cells. J Lipid Res 40 (1999) 345-353
16. Keys A., Menotti A., and Karvonen M.J. The diet and 15-year death rate in the Seven Countries Study. Am J Epidemiol 124 (1986) 903-915
17. Ferre N., Camps J., Fernandez-Ballart J., et al. Regulation of serum paraoxonase activity by genetic, nutritional and lifestyle factors in the general population. Clin Chem 49 (2003) 1491-1497
18. Petridou E., Malamou H., Doxiadis S., et al. Blood lipids in Greek adolescents and their relation to diet, obesity, and socioeconomic factors. Ann Epidemiol 5 (1995) 286-291
19. Skoumas J., Pitsavos C., Panagiotakos D.B., et al. Physical activity, high density lipoprotein cholesterol and other lipids levels, in men and women from the ATTICA Study. Lipids Health Dis 2 (2003) 3
20. Kesteloot H., Geboers J., and Pietinen P. On the within-population relationship between dietary habits and serum lipid levels in Belgium. Eur Heart J 8 (1987) 821-831
21. Kesteloot H., Geboers J., and Joossens J.V. On the within-population relationship between nutrition and serum lipids: the B.I.R.N.H. study. Eur Heart J 10 (1989) 196-202
22. Kesteloot H., and Sasaki S. On the relationship between nutrition, sex hormones and high-density lipoproteins in women. Acta Cardiol 48 (1993) 355-363
23. Libby P., Ridker P.M., and Maseri A. Inflammation and atherosclerosis. Circulation 105 (2002) 1135-1143
24. Danesh J., Collins R., Appleby P., et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279 (1998) 1477-1482
25. Navab M., Anantharamaiah G.M., Reddy S.T., et al. The double jeopardy of HDL. Ann Med 37 (2005) 1-6
26. Ansell B.J., Navab M., Hama S., et al. Inflammatory/anti-inflammatory properties of high-density lipoprotein distinguishing patients from control subjects better than high-density lipoprotein cholesterol levels and are favorable affected by simvastatin treatment. Circulation 108 (2003) 2751-2758
27. Rohde L.E., Hennekens C.H., and Ridker P.M. Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men. Am J Cardiol 84 (1999) 1018-1022
28. Koenig W., and Rosenson R.S. Emerging risk factors: acute-phase reactants: supplement on risk factors for coronary heart disease. Semin Vasc. Med. 2 (2002) 417-428
29. Panagiotakos D.B., Pitsavos C., Zeimbekis A., Chrysohoou C., and Stefanadis C. The association between lifestyle-related factors and plasma homocysteine levels in healthy individuals from the "ATTICA" Study. Int J Cardiol 98 3 (2005) 471-477
30. Dedoussis G.V., Panagiotakos D.B., Pitsavos C., et al. An association between the methylenetetrahydrofolate reductase (MTHFR) C677T mutation and inflammation markers related to cardiovascular disease. Int J Cardiol 100 3 (2005) 409-414
31. Brewer Jr. H.B. Increasing HDL cholesterol levels. N Engl J Med 350 (2004) 1505-1515
32. Ansell B.J., Watson K.E., Fogelman A.M., Navab M., and Fonarow G.C. High density lipoprotein function. JACC 46 (2005) 1792-1798